Abstract
1739P Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have